NIMI
CVS icon

Natixis Investment Managers International’s CVS Health CVS Stock Holding History

Natixis Investment Managers International’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$65.5K Hold
1,460
– – 0.01% 213
2024
Q3 		$91.8K Hold
1,460
– – 0.01% 198
2024
Q2 		$86.2K Hold
1,460
– – 0.01% 192
2024
Q1 		$116K Sell
1,460
-285
-16% -$21.8K 0.01% 171
2023
Q4 		$138K Buy
1,745
+404
+30% +$28.8K 0.01% 164
2023
Q3 		$93.6K Sell
1,341
-87
-6% -$6.16K 0.01% 196
2023
Q2 		$98.7K Sell
1,428
-88
-6% -$6.26K 0.01% 191
2023
Q1 		$113K Sell
1,516
-1,220
-45% -$102K 0.01% 182
2022
Q4 		$255K Sell
2,736
-471
-15% -$45.4K 0.02% 136
2022
Q3 		$305K Hold
3,207
– – 0.02% 109
2022
Q2 		$297K Sell
3,207
-7,969
-71% -$778K 0.01% 361
2022
Q1 		$1.13M Buy
11,176
+8,859
+382% +$931K 0.02% 201
2021
Q4 		$239K Buy
+2,317
New +$214K 0.01% 135
2018
Q4 		– Sell
-37,095
Closed -$2.92M – 162
2018
Q3 		$2.92M Buy
37,095
+7,803
+27% +$558K 0.14% 117
2018
Q2 		$1.89M Buy
29,292
+12,551
+75% +$827K 0.1% 140
2018
Q1 		$1.04M Buy
+16,741
New +$1.2M 0.07% 166
2017
Q4 		– Sell
-10,745
Closed -$874K – 211
2017
Q3 		$874K Sell
10,745
-696
-6% -$55.1K 0.08% 182
2017
Q2 		$921K Sell
11,441
-9,956
-47% -$786K 0.08% 196
2017
Q1 		$1.68M Buy
21,397
+8,681
+68% +$693K 0.15% 103
2016
Q4 		$1M Buy
12,716
+7,027
+124% +$569K 0.09% 160
2016
Q3 		$506K Buy
5,689
+2,096
+58% +$198K 0.05% 268
2016
Q2 		$344K Sell
3,593
-2,965
-45% -$295K 0.04% 291
2016
Q1 		$680K Sell
6,558
-2,034
-24% -$198K 0.08% 129
2015
Q4 		$840K Hold
8,592
– – 0.11% 105
2015
Q3 		$829K Sell
8,592
-175
-2% -$18.4K 0.11% 128
2015
Q2 		$919K Buy
8,767
+209
+2% +$21.4K 0.11% 127
2015
Q1 		$883K Buy
8,558
+30
+0.4% +$3.04K 0.11% 130
2014
Q4 		$821K Buy
+8,528
New +$751K 0.11% 134

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Natixis Investment Managers International's CVS Position: Q4 2024 in Review

Natixis Investment Managers International held its CVS Health (CVS) position steady in Q4 2024 at 1,460 shares worth $65.5K. The position accounts for 0.01% of the portfolio, ranked #213.

Natixis Investment Managers International first reported a position in CVS in Q4 2014 and has held it in 28 quarters since. The position peaked at $2.92M in Q3 2018. 1,669 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Natixis Investment Managers International held 1,460 shares of CVS Health worth $65.5K as of Q4 2024.
  • Natixis Investment Managers International left its CVS Health share count unchanged in Q4 2024.
  • CVS Health made up 0.01% of Natixis Investment Managers International's portfolio in Q4 2024, its #213 holding.
  • Natixis Investment Managers International first reported a position in CVS Health in Q4 2014 and has held it in 28 quarters since.
  • Natixis Investment Managers International's CVS Health position peaked at $2.92M in Q3 2018.
  • 1,669 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Natixis Investment Managers International's 13F filing for Q4 2024, filed 13 Feb 2025.